Skip to content

Evaluation of the Analgesic effect of Lidocaine when used Topically or Intravenously before Tracheal Intubation in patients under General Anesthesia

Evaluation of the Antinociceptive effect of Topical or Intravenous Lidocaine prior to Tracheal Intubation in patients undergoing General Anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-7ktpgx7
Enrollment
Unknown
Registered
2025-07-07
Start date
2023-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, General. Intubation, Intratracheal

Interventions

This is a prospective randomized clinical trial in adult patients undergoing general anesthesia with indication for orotracheal intubation. The eligible patient will proceed to randomization to the co
E03.155.197.197.640

Sponsors

Universidade Federal de São Paulo - UNIFESP/EPM
Lead Sponsor
Hospital São Paulo - SPDM
Collaborator

Eligibility

Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients indicated for elective surgical interventions under general anesthesia and tracheal intubation; both genders; age between 18 and 80 years; American Society of Anesthesiologists physical status classification ASA I or II

Exclusion criteria

Exclusion criteria: Emergency procedures; psychiatric disorders; suspected difficult airway; contraindication to manual ventilation under a face mask; use of beta-blockers; cardiac arrhythmia; use of opioids or other illicit drugs

Design outcomes

Primary

MeasureTime frame
To evaluate whether there is an additive anti-nociceptive effect to the drugs used in the induction of general anesthesia with 2% lidocaine solution without vasopressor administered prior to tracheal intubation. This assessment will be made using the NOL variation gradient (measured by the NOL Medasense monitor) pre and post intubation.

Secondary

MeasureTime frame
To evaluate whether there is a preferred route for administering 2% lidocaine solution without vasopressor - intravenous or laryngotracheal - in terms of reducing nociception associated with tracheal intubation.

Countries

Brazil

Contacts

Public ContactSimone Abib

Universidade Federal de São Paulo - UNIFESP/EPM

simoneabib@uol.com.br+55(11)5576-4848

Outcome results

None listed

Source: REBEC (via WHO ICTRP)